Register Login

STANDARD BIOTOOLS INC. (LAB)

Egholm Michael 🟡 adjusted position in 3.3M shares (2 derivative) of STANDARD BIOTOOLS INC. (LAB) at $0.98 ($2.4M) Transaction Date: Mar 20, 2026 | Filing ID: 148615

Full text
Register to leave comments
  • News bot April 9, 2026, 1:55 a.m.

    🔍 Egholm Michael (Executive)

    Company: STANDARD BIOTOOLS INC. (LAB)

    Report Date: 2026-03-20

    Transaction Summary:

    • Total transactions: 5
    • Derivative instruments: 2
    • Holdings reported: 0
    • Total shares acquired: 3,584,226
    • Total shares sold: 291,527

    Detailed Transactions and Holdings:

    • Acquired 1,042,373 shares of Common Stock (Direct)
      Date: 2026-03-20 | Code: A | equity_swap_involved: false | shares_owned_after: 6,594,083.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 196,513 shares of Common Stock (Direct)
      Date: 2026-04-06 | Code: M | equity_swap_involved: false | shares_owned_after: 6,790,596.00 | transaction_form_type: 4
    • Sold 95,014 shares of Common Stock at $0.908 per share (Direct)
      Date: 2026-04-06 | Code: F | equity_swap_involved: false | shares_owned_after: 6,695,582.00 | transaction_form_type: 4 | Footnotes: F2
    • Acquired 2,345,340 shares of Stock Option (Right to buy) at $0.9846 per share (Derivative)
      Date: 2026-03-20 | Code: A | Expires: 2036-03-20 | equity_swap_involved: false | shares_owned_after: 2,345,340.00 | transaction_form_type: 4 | Footnotes: F3
    • Sold 196,513 shares of Restricted Stock Units (Derivative)
      Date: 2026-04-06 | Code: M | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F4, F5, F5

    Footnotes:

    • F1: Represents restricted stock units ("RSUs") that vest over four years, with 1/16 of the RSUs vesting on May 20, 2026 and the remaining RSUs vesting in equal quarterly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting.
    • F2: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of RSUs granted to the reporting person on April 4, 2022, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on April 6, 2022.
    • F3: The Option becomes exercisable as to 1/16th of the underlying shares on May 20, 2026, with the remaining shares vesting in equal quarterly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.
    • F4: Each RSU represents the contingent right to receive one share of the Issuer's common stock.
    • F5: On April 4, 2022, the Reporting Person was granted 786,049 RSUs, vesting in four equal annual installments beginning on April 4, 2023.

Search

News categories